Fractures and bisphosphonates: reviving osteoporosis treatment uptake by identifying the genetic, material, and microstructural risk factors of atypical femur fractures

  • Ebeling, Peter (Primary Chief Investigator (PCI))
  • Grill, Vivian (Chief Investigator (CI))
  • Sztal-Mazer, Shoshana (Chief Investigator (CI))
  • Seeman, Ego (Chief Investigator (CI))
  • Yates, Christopher J (Chief Investigator (CI))
  • Sinnott, Richard (Chief Investigator (CI))
  • Clifton-Bligh, Roderick (Chief Investigator (CI))
  • Zillikens, M Carola (Chief Investigator (CI))
  • Ng, Alvin (Chief Investigator (CI))
  • Adams, Annette (Chief Investigator (CI))
  • Thakker, Rajesh V (Chief Investigator (CI))

Project: Other

Short titleAmgen TRAFFIC Grant
AcronymAmgenTRAFFIC
StatusActive
Effective start/end date5/07/194/07/22

Funding

  • Amgen Australia Pty Ltd: AUD150,000.00